Tubular β-Catenin Ameliorates AKI by Restoring Mitochondrial Biogenesis
Rattachement africain : hk, cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Renal tubular β-catenin signaling plays a protective role in acute kidney injury (AKI), but the underlying mechanisms remain unclear. Mitochondrial dysfunction is responsible for the pathogenesis of AKI. This study aims to investigate the role of β-catenin activation on mitochondrial biogenesis in tubular cells upon AKI and its underlying mechanism. Methods: Loss- and gain-of-β-catenin function was established in mice with tubular cell-specific β-catenin stabilization (TubCat mice) and knockout (TubCatKO mice). Septic and aseptic AKI was induced by exposure to LPS or ischemia/reperfusion, respectively. Kidney injury was examined by NGAL immunohistochemical staining. Markers of mitochondrial biogenesis were determined by Western blot, real-time quantitative PCR and immunofluorescence staining. Signaling cascade was examined by Western blot. Results: Compared to the controls, TubCat mice under septic and aseptic AKI had significantly alleviated kidney injury and enhanced mitochondrial biogenesis as indicated by (i) reduction of NGAL positive tubules; (ii) restoration of mitochondrial mass protein TOMM20 and mitochondrial biogenesis molecules PGC-1α and NRF1; (iii) increasing co-localization of PGC-1α and β-catenin in renal tubules and (iv) increasing FOXO3 signaling against septic and aseptic injury. Consistently, kidney injury, and mitochondrial dysfunction were aggravated in TubCatKO mice versus their control littermates. Conclusions: In both septic and aseptic AKI, tubular β-catenin stabilization restores mitochondrial homeostasis through the FOXO3/PGC-1α signaling pathway. Funding: General Research Fund (HKU 17119818), RGC Collaborative Research Fund (Ref: C7018-16G) and Hong Kong Society of Nephrology Research Grant (2019)
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Tubular β-Catenin Ameliorates AKI by Restoring Mitochondrial Biogenesis
- Date Crossref
- 01/10/2021
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.